TCF7L2
View/Edit Human | View/Edit Mouse |
Transcription factor 7-like 2 (T-cell specific, HMG-box), also known as TCF7L2 or TCF4, is a protein acting as a transcription factor that, in humans, is encoded by the TCF7L2 gene.[5][6] The TCF7L2 gene is located on chromosome 10q25.2–q25.3, contains 19 exons.[7][8] As a member of the TCF family, TCF7L2 can form a bipartite transcription factor and influence several biological pathways, including the Wnt signalling pathway.[9]
Function
TCF7L2 is a transcription factor influencing the
The TCF7L2 gene encoding the TCF7L2 transcription factor, exhibits multiple functions through its polymorphisms and thus, is known as a pleiotropic gene. Type 2 diabetes T2DM susceptibility is exhibited in carriers of TCF7L2 rs7903146C>T[24][25] and rs290481T>C[25] polymorphisms.[24][25] TCF7L2 rs290481T>C polymorphism, however, has shown no significant correlation to the susceptibility to gestational diabetes mellitus (GDM) in a Chinese Han population, whereas the T alleles of rs7903146[25] and rs1799884[10] increase susceptibility to GDM in the Chinese Han population.[25][10] The difference in effects of the different polymorphisms of the gene indicate that the gene is indeed pleiotropic.
Structure
The TCF7L2 gene, encoding the TCF7L2 protein, is located on chromosome 10q25.2-q25.3. The gene contains 19 exons.[7][8] Of the 19 exons, 5 are alternative.[8] The TCF7L2 protein contains 619 amino acids and its molecular mass is 67919 Da.[26] TCF7L2's secondary structure is a helix-turn-helix structure.[27]
Tissue distribution
TCF7L2 is primarily expressed in brain (mainly in the diencephalon, including especially high in the thalamus[23][28][29]), liver, intestine and fat cells. It does not primarily operate in the β-cells in the pancreas.[30]
Clinical significance
Type 2 Diabetes
Several single nucleotide polymorphisms within the TCF7L2 gene have been associated with type 2 diabetes. Studies conducted by Ravindranath Duggirala and Michael Stern at The University of Texas Health Science Center at San Antonio were the first to identify strong linkage for type 2 diabetes at a region on Chromosome 10 in Mexican Americans [31] This signal was later refined by Struan Grant and colleagues at DeCODE genetics and isolated to the TCF7L2 gene.[32] The molecular and physiological mechanisms underlying the association of TCF7L2 with type 2 diabetes are under active investigation, but it is likely that TCF7L2 has important biological roles in multiple metabolic tissues, including the pancreas, liver and adipose tissue.[30][33] TCF7L2 polymorphisms can increase susceptibility to type 2 diabetes by decreasing the production of glucagon-like peptide-1 (GLP-1).[9]
Gestational Diabetes (GDM)
TCF7L2 modulates pancreatic islet β-cell function strongly implicating its significant association with GDM risk.[10] T alleles of rs7903146[25] and rs1799884[10] TCF7L2 polymorphisms increase susceptibility to GDM in the Chinese Han population.[25][10]
Cancer
TCF7L2 plays a role in
Variants of the gene are most likely involved in many other cancer types.[36] TCF7L2 is indirectly involved in prostate cancer through its role in activating the PI3K/Akt pathway, a pathway involved in prostate cancer.[37]
Neurodevelopmental disorders
Single nucleotide polymorphisms (SNPs) in TCF7L2 gene have shown an increase in susceptibility to schizophrenia in Arab, European and Chinese Han populations.[citation needed] In the Chinese Han population, SNP rs12573128[14] in TCF7L2 is the variant that was associated with an increase in schizophrenia risk. This marker is used as a pre-diagnostic marker for schizophrenia.[14] TCF7L2 has also been reported as a risk gene in autism spectrum disorder[38] and has been linked to it in recent large-scale genetic studies.[15][16]
The mechanism behind TCF7L2's involvement in the emergence of neurodevelopmental disorders is not fully understood, as there have been few studies characterizing its role in brain development in detail. It was shown that during embryogenesis TCF7L2 is involved in the development of fish-specific habenula asymmetry in Danio rerio,[39][40] and that the dominant negative TCF7L2 isoform influences cephalic separation in the embryo by inhibiting the posteriorizing effect of the Wnt pathway.[41] It was also shown that in Tcf7l2 knockout mice the number of proliferating cells in cortical neural progenitor cells is reduced.[42] In contrast, no such effect was found in the midbrain.[43]
More recently it was shown that TCF7L2 plays a crucial role in both the embryonic development and postnatal maturation of the thalamus through direct and indirect regulation of many genes previously reported to be important for both processes.[23] In late gestation TCF7L2 regulates the expression of many thalamus-enriched transcription factors (e.g. Foxp2, Rora, Mef2a, Lef1, Prox1), axon guidance molecules (e.g. Epha1, Epha4, Ntng1, Epha8) and cell adhesion molecules (e.g. Cdh6, Cdh8, Cdhr1). Accordingly, a total knockout of Tcf7l2 in mice leads to improper growth of thalamocortical axons, changed anatomy and improper sorting of the cells in the thalamo-habenular region.[23] In the early postnaral period TCF7L2 starts to regulate the expression of many genes necessary for the acquisition of characteristic excitability patterns in the thalamus, mainly ion channels, neurotransmitters and their receptors and synaptic vescicle proteins (e.g. Cacna1g, Kcnc2, Slc17a7, Grin2b), and an early postnatal knockout of Tcf7l2 in mouse thalamus leads to significant reduction in the number and frequency of action potentials generated by the thalamocortical neurons.[23] The mechanism that leads to the change in TCF7L2 target genes between gestation and early postnatal period is unknown. It is likely that a perinatal change in the proportion of TCF7L2 isoforms expressed in the thalamus is partially responsible.[28] Abnormalities in the anatomy of the thalamus and the activity of its connections to the cerebral cortex are frequently detected in patients with schizophrenia [44][45][46][47] and autism.[48][49][50][51] Such abnormalities could arise from developmental aberrations in patients with unfavorable mutations of TCF7L2, further strengthening the link between TCF7L2 and neurodevelopmental disorders.
Multiple sclerosis
TCF7L2 is downstream of the
Model organisms
Variations of the protein encoding gene are found in rats, zebra fish, drosophila, and budding yeast.[59] Therefore, all of those organisms can be used as model organisms in the study of TCF7L2 function.
Nomenclature
TCF7L2 is the symbol officially approved by the HUGO Gene Nomenclature Committee for the Transcription Factor 7-Like 2 gene.
See also
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000148737 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000024985 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: TCF7L2".
- PMID 1741298.
- ^ a b "TCF7L2 transcription factor 7 like 2 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-11-30.
- ^ a b c d Online Mendelian Inheritance in Man (OMIM): TRANSCRIPTION FACTOR 7-LIKE 2;TCF7L2 - 602228{
- ^ PMID 18599616.
- ^ PMID 23690305.
- PMID 25533962.
- PMID 28135719.
- S2CID 42205809.
- ^ PMID 28404897.
- ^ PMID 33004838.
- ^ PMID 31981491.
- ^ PMID 29131639.
- ^ S2CID 4620853.
- S2CID 35065699.
- PMID 17052462.
- PMID 16567498.
- PMID 28851992.
- ^ PMID 32675279.
- ^ PMID 29128291.
- ^ PMID 29100364.
- ^ Database, GeneCards Human Gene. "TCF7L2 Gene - GeneCards | TF7L2 Protein | TF7L2 Antibody". www.genecards.org. Retrieved 2017-11-30.
- ^ "TCF7L2 - Transcription factor 7-like 2 - Homo sapiens (Human) - TCF7L2 gene & protein". www.uniprot.org. Retrieved 2017-11-30.
- ^ PMID 23152144.
- PMID 19005066.
- ^ PMID 23431017.
- PMID 10090898.
- S2CID 28825825.
- PMID 27159876.
- PMID 18398040.
- PMID 18478343.
- PMID 18621708.
- S2CID 10148857.
- ^ "SFARI Gene Databse - TCF7L2". Retrieved 2022-07-16.
- PMID 24067090.
- PMID 25201686.
- PMID 21856776.
- PMID 29751817.
- PMID 28219675.
- PMID 30597053.
- PMID 27531067.
- PMID 30409697.
- PMID 29960671.
- PMID 33536431.
- PMID 27125303.
- PMID 29300843.
- PMID 28584881.
- S2CID 85911512.
- ^ "International Mouse Phenotyping Consortium".
- PMID 21677750.
- PMID 21677718.
- S2CID 18872015.
- PMID 23870131.
- ^ "Infection and Immunity Immunophenotyping (3i) Consortium".
- ^ "MARRVEL: Search Result". marrvel.org. Retrieved 2017-11-30.
Further reading
- Segditsas S, Tomlinson I (December 2006). "Colorectal cancer and genetic alterations in the Wnt pathway". Oncogene. 25 (57): 7531–7537. PMID 17143297.
- Florez JC (July 2007). "The new type 2 diabetes gene TCF7L2". Current Opinion in Clinical Nutrition and Metabolic Care. 10 (4): 391–396. S2CID 21362394.
- Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–174. PMID 8125298.
- Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. (March 1997). "Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma". Science. 275 (5307): 1784–1787. S2CID 33935423.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–156. PMID 9373149.
- He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. (September 1998). "Identification of c-MYC as a target of the APC pathway". Science. 281 (5382): 1509–1512. PMID 9727977.
- Barker N, Huls G, Korinek V, Clevers H (January 1999). "Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium". The American Journal of Pathology. 154 (1): 29–35. PMID 9916915.
- Omer CA, Miller PJ, Diehl RE, Kral AM (March 1999). "Identification of Tcf4 residues involved in high-affinity beta-catenin binding". Biochemical and Biophysical Research Communications. 256 (3): 584–590. PMID 10080941.
- Giannini AL, Vivanco MM, Kypta RM (March 2000). "Analysis of beta-catenin aggregation and localization using GFP fusion proteins: nuclear import of alpha-catenin by the beta-catenin/Tcf complex". Experimental Cell Research. 255 (2): 207–220. PMID 10694436.
- Duval A, Busson-Leconiat M, Berger R, Hamelin R (2000). "Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3". Cytogenetics and Cell Genetics. 88 (3–4): 264–265. S2CID 13148464.
- Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R (July 2000). "The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines". Cancer Research. 60 (14): 3872–3879. PMID 10919662.
- Brantjes H, Roose J, van De Wetering M, Clevers H (April 2001). "All Tcf HMG box transcription factors interact with Groucho-related co-repressors". Nucleic Acids Research. 29 (7): 1410–1419. PMID 11266540.
- Palacino JJ, Murphy MP, Murayama O, Iwasaki K, Fujiwara M, Takashima A, et al. (October 2001). "Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion". The Journal of Biological Chemistry. 276 (42): 38563–38569. PMID 11504726.
- Miravet S, Piedra J, Miró F, Itarte E, García de Herreros A, Duñach M (January 2002). "The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin". The Journal of Biological Chemistry. 277 (3): 1884–1891. PMID 11711551.
- Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W (December 2001). "Tcf4 can specifically recognize beta-catenin using alternative conformations". Nature Structural Biology. 8 (12): 1048–1052. S2CID 33878077.
- Poy F, Lepourcelet M, Shivdasani RA, Eck MJ (December 2001). "Structure of a human Tcf4-beta-catenin complex". Nature Structural Biology. 8 (12): 1053–1057. S2CID 24798619.
- Thiele A, Wasner M, Müller C, Engeland K, Hauschildt S (December 2001). "Regulation and possible function of beta-catenin in human monocytes". Journal of Immunology. 167 (12): 6786–6793. PMID 11739494.
- Marchenko GN, Marchenko ND, Leng J, Strongin AY (April 2002). "Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin". The Biochemical Journal. 363 (Pt 2): 253–262. PMID 11931652.
- Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, et al. (June 2002). "Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling". The Journal of Biological Chemistry. 277 (24): 21657–21665. PMID 11940574.
External links
- TCF7L2 here called TCF4 features on this Wnt pathway web site: Wnt signalling molecules TCFs
- Structure determination of TCF7L2: PDB entry 2GL7 and related publication on PubMed
- PubMed GeneRIFs (summaries of related scientific publications) - [1]
- Weizmann Institute GeneCard for TCF7L2
- Overview of all the structural information available in the PDB for UniProt: Q9NQB0 (Transcription factor 7-like 2) at the PDBe-KB.